More than 140 teams of researchers are racing to develop a safe and effective coronavirus vaccine.

Researchers around the world are racing to develop a vaccine against Covid-19, with more than 140 candidate vaccines now tracked by the World Health Organization (WHO).

Vaccines normally require years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine within 12 to 18 months.

Vaccines mimic the virus – o...

Nature publishes an article talking about COVID-19 and cardiovascular disease.
Coronavirus disease 2019 (COVID-19), caused by a strain of coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic that has affected the lives of billions of individuals. Extensive studies have revealed that SARS-CoV-2 shares many biological features with SARS-CoV, the zoonotic virus that caused the 2002 outbreak of severe acute respiratory syndrome, includ...

Managing COVID-19 in Surgical Systems

Annals of Surgery published this paper about surgical systems.As COVID-19 spreads quickly from Europe and Asia to the rest of the world, hospitals are rapidly becoming hot zones for treatment and transmission of this disease in settings with rising community transmission. Health care workers are increasingly contracting this illness, decreasing the human resources available to care for a population in crisis.
For further reading click th...

Edición genética con CRISPR y estudios de serovigilancia, nuevos informes del Grupo ISCIII de Análisis sobre Coronavirus

El Grupo de Análisis Científico sobre Coronavirus del ISCIII ha publicado dos nuevos informes, sobre los posibles usos de la tecnología CRISPR de edición genética y sobre el desarrollo de estudios de serovigilancia epidemiológica, que como en casos anteriores incluyen un resumen divulgativo y un texto completo de carácter científico-técnico.
...

The preliminary results of a clinical trial suggest a new treatment for Covid-19 reduces the number of patients needing intensive care, according to the UK company that developed it.

The treatment from Southampton-based biotech Synairgen uses a protein called interferon beta which the body produces when it gets a viral infection.

The protein is inhaled directly into the lungs of patients with coronavirus, using a nebuliser, in the hope that it will stimulate an immune respon...

British Journal of Surgery publishes an article talking about how surgeons adapt to new normal.
An optimized workflow is mandatory to restore surgical care to the population in the ‘new‐normal’ of COVID‐19 pandemic1-3. Our hospital was the largest tertiary centre in Beijing that continued to provide full‐ranged surgical care from January 26 through April 29. We have received 99 809 surgical outpatients and 4376 emergencies, and 5378 surgeries have been performed. We herein introduce our mo...

WHO Director-General's opening remarks at the media briefing on COVID-19 - 23 July 2020
Good morning, good afternoon and good evening.

More than 15 million cases of COVID-19 have now been reported to WHO, and almost 620 thousand deaths.

Although all countries have been affected, we continue to see intense transmission in a relatively small group of countries.

Almost 10 million cases, or two-thirds of all cases globally, are from 10 countries, and almost half of all cas...